Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares Sold by Rhumbline Advisers
Rhumbline Advisers reduced its holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 4.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 236,030 shares of the biopharmaceutical company’s stock after selling 10,884 shares during the period. Rhumbline Advisers’ holdings in Esperion Therapeutics were worth $340,000 at the end of the most recent […]
Rhumbline Advisers reduced its holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 4.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 236,030 shares of the biopharmaceutical company’s stock after selling 10,884 shares during the period. Rhumbline Advisers’ holdings in Esperion Therapeutics were worth $340,000 at the end of the most recent […]
